As the coronavirus pandemic continues to ravage parts of the developing world, there are growing calls to make vaccines more accessible and affordable by waiving their patents.
On the front line of India's coronavirus fight, vaccines are among its most potent weapons.
To cope with the unprecedented surge in cases, India's government have made vaccination available to anyone over the age of 18.
But despite being the world's largest manufacturer of vaccines, the nation is already experiencing a shortages of doses.
Now India and South Africa are leading a push at the World Trade Organisation ((WTO)) to try and solve the global shortages of vaccines.
They've asked the W-T-O to intervene and waive the patents, or intellectual property, on coronavirus vaccines.





